Determinants of fasting plasma total homocysteine levels among chronic stable renal transplant recipients

被引:49
作者
Bostom, AG
Gohh, RY
Beulieu, AJ
Han, H
Jacques, PF
Selhub, J
Dworkin, L
Rosenberg, IH
机构
[1] Mem Hosp Rhode Isl, Div Gen Internal Med, Pawtucket, RI 02860 USA
[2] Mem Hosp Rhode Isl, Div Cardiol, Pawtucket, RI 02860 USA
[3] Rhode Isl Hosp, Div Renal Dis, Providence, RI USA
[4] Tufts Univ, USDA, Jean Mayer Human Nutr Res Ctr Aging, Boston, MA 02111 USA
关键词
D O I
10.1097/00007890-199907270-00017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Although several studies have demonstrated an unadjusted association between folate status and fasting plasma total homocysteine (tHcy) levels among renal transplant recipients, no data confirming the strength or independence of this association have been reported. Methods. We determined fasting plasma folate, B-12, and pyridoxal 5'-phosphate (active vitamin B-6) levels, along with other potential determinants of plasma tHcy levels (i.e., age, sex, creatinine levels, and Cockcroft-Gault estimated creatinine clearance, current immunosuppressive regimen, and history of clinical cardiovascular disease), among 86 renal transplant recipients. The recipients were greater than or equal to 6 months after transplantation, lived in the Providence, Rhode Island metropolitan area, and were examined between February and June 1998. Results. Stepwise general linear modeling with analysis of covariance revealed that only creatinine level, age, and vitamin status were independent regressors (i.e., P<0.100) of tHcy levels. Moreover, creatinine level alone determined most of the variability in tHcy levels (i.e., R-2) accounted for by these independent variables (R-2=0.416 for creatinine level alone; total R-2=0.575). In contrast, the R-2 for folate alone was only 0.046, and even for all three B vitamins combined, the R-2 was just 0.088. Conclusions. We conclude that renal function is the overriding independent determinant of fasting tHcy levels among stable renal transplant recipients. In comparison to renal function, vitamin status has a relatively marginal influence on tHcy levels and cyclosporine use has essentially none at all.
引用
收藏
页码:257 / 261
页数:5
相关论文
共 22 条
[1]   Serum total homocysteine concentration before and after renal transplantation [J].
Arnadottir, M ;
Hultberg, B ;
Wahlberg, J ;
Fellström, B ;
Dimény, E .
KIDNEY INTERNATIONAL, 1998, 54 (04) :1380-1384
[2]   Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients [J].
Arnadottir, M ;
Hultberg, B ;
Vladov, V ;
NilssonEhle, P ;
Thysell, H .
TRANSPLANTATION, 1996, 61 (03) :509-512
[3]   NET UPTAKE OF PLASMA HOMOCYSTEINE BY THE RAT-KIDNEY IN-VIVO [J].
BOSTOM, A ;
BROSNAN, JT ;
HALL, B ;
NADEAU, MR ;
SELHUB, J .
ATHEROSCLEROSIS, 1995, 116 (01) :59-62
[4]   High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients [J].
Bostom, AG ;
Shemin, D ;
Lapane, KL ;
Hume, AL ;
Yoburn, D ;
Nadeau, MR ;
Bendich, A ;
Selhub, J ;
Rosenberg, IH .
KIDNEY INTERNATIONAL, 1996, 49 (01) :147-152
[5]   Treatment of hyperhomocysteinemia in renal transplant recipients - A randomized, placebo-controlled trial [J].
Bostom, AG ;
Gohh, RY ;
Beaulieu, AJ ;
Nadeau, MR ;
Hume, AL ;
Jacques, PF ;
Selhub, J ;
Rosenberg, IH .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (12) :1089-1092
[6]   Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes [J].
Bostom, AG ;
Lathrop, L .
KIDNEY INTERNATIONAL, 1997, 52 (01) :10-20
[7]   Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients [J].
Bostom, AG ;
Gohh, RY ;
Tsai, MY ;
HopkinsGarcia, BJ ;
Nadeau, MR ;
Bianchi, LA ;
Jacques, PF ;
Rosenberg, IH ;
Selhub, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) :1894-1900
[8]  
Brattström L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894
[9]  
Chauveau P, 1996, MINER ELECTROL METAB, V22, P106
[10]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41